×
Personalis Total Long Term Liabilities 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis total long term liabilities from 2018 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
View More
Personalis Total Long Term Liabilities 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis total long term liabilities from 2018 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.9B
BridgeBio Pharma (BBIO)
$4.4B
Bausch Health Cos (BHC)
$2.9B
Amphastar Pharmaceuticals (AMPH)
$2.2B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$506M
Assembly Biosciences (ASMB)
$96M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M